The objective of these studies was to assess the effects of the tripeptides, L-valyl-L-prolyl-L-proline (VPP) and L-isoleucyl-L-prolyl-L-proline (IPP), on reproductive capabilities of male and female rats. The specific goals of the experiments were (1) to determine the effects of orally administered tripeptides on (a) fertility and reproductive behavior in both sexes of rats, (b) embryo-fetal development in pregnant rats, and (c) pre-and postnatal development of rats exposed to tripeptides in utero and during lactation; and (2) to estimate the no-observable-adverse-effect doses of tripeptides in maternal and fetal rats. During the conduct of these classical segment I, II, and III studies, the test material was powdered Lactobacillus helveticus-fermented milk (FM), which contains the tripeptides, VPP and IPP. FM (0, 500, 1000 or 2000 mg/kg body weight [BW]/day-equivalent to 0, 0.8, 1.6, or 3.3 mg/kg BW/day of VPP plus IPP) was administered to males by oral gavage from 4 weeks prior to mating until sacrifice, and to females from 2 weeks prior to mating through day 20 of lactation. Evaluative parameters included monitoring grossly observable clinical signs; food consumption and body weight gains; mating behavior and fertility indices of both sexes; implantation and maintenance of embryos; sex ratio of live pups; fetal viability; incidences of external, visceral or skeletal variations; growth and behavioral development; as well as reproductive capabilities of F 1 offspring exposed to FM during gestation and lactation. All animals were subjected to macroscopic examination at termination of their segment of the studies. Clinical signs, body weights, and food consumption were unaffected by administration of FM. During segment I, the test agent had no effect on estrus cycle, mating behavior, fertility index, or reproductive competence of either males or females. The results of segment II experiments revealed no effects of FM on postimplantation survival-loss, sex ratio or birth weights of live fetuses, and there was no evidence of treatment-associated developmental or teratological effects. During segment III, FM was without effect on pup viability, behavioral and sexual maturation, and reproductive capability of the F 1 generation. Under the conditions of these experiments, the no-observable-adverse-effect level (NOAEL) of FM on reproductive performance in male and female rats is greater than 2000 mg/kg BW/day, the equivalent of 3.3 mg/kg BW/day of VPP plus IPP.
INTRODUCTION
The consumption of fermented milk to maintain good health, including the maintenance of normal blood pressure, is an ancient tradition in a number of areas of the world (e.g., East Asia, France). Recent studies have suggested that fermented milk has a normotensive effect in hypertensive rats and humans, but no effect on blood pressure in normotensive humans. However, to date there has been no systematic attempt to perform and publish the results of evaluations relevant to a scientifically sound assessment of the safety of fermented milk or its biologically active constituents. This paper is one in a series of nine publications, all of which are presented in the same issue of the International Journal of Toxicology. It is the purpose of these publications to bring together the results of the relatively few currently 62 TOXICOLOGICAL ASSESSMENT OF TRIPEPTIDES VPP AND IPP published articles and to publish, for the first time, a significant body of research on the safety/toxicological potential.
Prompted by early scientific results, additional research sought to determine the source of the biological effect and revealed that cardiovascular activity resided in two naturally occurring and well-defined tripeptides, specifically, L-valyl-Lprolyl-L-proline (VPP) and L-isoleucyl-L-prolyl-L-proline (IPP). A process for controlling the production of these tripeptides was developed consisting of fermenting reconstituted powdered skim milk using a starter culture containing Lactobacillus helveticus.
In 1997, products containing VPP plus IPP were approved for manufacture, sale and consumption in Japan by the Ministry of Health, Labor, and Welfare, under the Food for Specified Health Use (FOSHU) regulations. These tripeptides-containing products have been sold continuously in Japan since 1997 and include both pasteurized fermented milk drinks and tablets.
The physical and chemical properties of VPP and IPP have been presented in Bernard et al. 2005b. To summarize, VPP (CAS no. 58872-39-2) , a white powder with a melting point of 198.5
• C, has a molecular weight of 311.4, and a chemical formula of C 15 H 25 N 3 O 4 . IPP (CAS no. 26001-32-1) is also a white powder but with a lower melting point (125.9 • C), a molecular weight of 325.3, and a chemical formula of C 16 H 27 N 3 O 4 . Naturally occurring VPP plus IPP is consumed in a number of foods, including dairy products, most notably in cheeses. Estimating its consumption from food sources is difficult owing to the variability of concentrations even within the same food type (e.g., concentrations of VPP plus IPP vary as much as 10-fold in various brands of cheddar cheese). A high, but not unreasonable, estimate of possible VPP plus IPP ingestion from consumption of cheese is 2,988 mg/person/year, which is equivalent to 8.2 mg/person/day or 0.11 mg/kg body weight (BW)/day ). This compares with the average consumption from VPP plus IPP-enhanced foods in Japan: 106.8 mg/person/year, which is equivalent to approximately 0.3 mg/person/day or 0.005 mg/kg BW/day (based upon a 60-kg Japanese individual) .
In a previous publication, scientific data were reviewed and it was concluded that VPP plus IPP was active in the maintenance of normal blood pressure in hypertensive rats and humans, while no effect on blood pressure was observed in normotensive rats and humans .
Consideration is being given to enhancing natural VPP plus IPP levels in yogurt for consumption in the United States. This enhancement could result in an increase in mean VPP plus IPP consumption of 118.1 g/person/day or 0.1 mg/kg BW/day based on a 75-kg average American . Prior to such a consideration, substantial evaluation and study of the safety of VPP plus IPP should be undertaken. It has been reported that the single-oral-dose, no-observable-effect levels (NOELs) for powdered L. helveticus-fermented milk (FM), powdered casein hydrolysate (CH) (both containing known levels of VPP plus IPP) and synthetic VPP were equal to or greater than 4000, 2000, and 400 mg/kg, respectively. Similarly, no signs of toxicity were observed when FM was administered orally for 28 consecutive days at a dose of 2000 mg/kg (Maeno et al. 2005b) . When the synthetic peptide (VPP) itself was administered in the diet (0, 2, 8, or 16 mg/kg BW/day) for 8 weeks, neither rats nor Beagle dogs exhibited detectable toxicity (Nakamura et al 2005) . The longest study performed to date, a 91-day gavage study in rats (Mizuno et al. 2005) , employed as the test article, powdered casein hydrolysate (CH) known to contain 0.6% VPP plus IPP. Once a day doses as high as 1000 mg CH/kg BW/day (equivalent to 6 mg VPP plus IPP/kg BW/day) were reported to elicit no observable toxicological sequelae.
The current paper continues and expands the evaluation of the potential toxicity of VPP and IPP by evaluating potential effects of these tripeptides on (a) rat fertility and reproductive behavior; (b) embryofetal development in pregnant rats; and (c) pre-and postnatal development of rats exposed to tripeptides in utero and during lactation.
MATERIALS AND METHODS

Factors Common to All Experiments The Test Substance and Dosage Preparation
The test substance is a powdered concentrate of fermented milk containing the tripeptides VPP and IPP. These tripeptides are natural components of FM produced by the action of Lactobacillus helveticus on reconstituted powdered skim milk.
The sample of powdered FM used in these studies was stored at 20 • C and assayed to assure test article stability. The results of this series of assays are summarized in Table 1 . During the 5-month period of storage at 20 • C, the concentrations of the tripeptides (VPP, IPP) remained constant.
Dosing solutions of powdered FM were prepared weekly in water for injection (J.P. Fuso Pharmaceutical Industries, Ltd., Lot No.00512D). Prepared dosing solutions were stored and frozen at approximately −20 • C in screw-capped plastic tubes in quantities sufficient for a single day's administration. Frozen aliquots were brought to room temperature before administration. Oral doses of the powdered FM employed in these studies were 0, 500, 1000, and 2000 mg/kg BW/day (equivalent to 0, 0.8, 1.6, and 3.3 mg VPP plus IPP/kg BW/day). Experimental groups were designated group G1 (vehicle control), G2 (500 mg/kg), G3 (1000 mg/kg), and G4 (2000 mg/kg).
Animals and Animal Husbandry
Male and female Sprague-Dawley rats (Crj: CD (SD) IGS; Charles River Japan) were acclimated to laboratory conditions for approximately one week prior to initiation of each experiment. Upon receipt, males were 7 to 11 weeks old and females were 8 to 10 weeks old. Except during mating periods, animals were housed individually in stainless steel cages.
During mating trials, single males and single females were cohabited. The female rats were housed in plastic cages with bedding (Clean chip; Clea Japan Inc.) individually or together with litters during the terminal phase of gestation and lactation period. Each morning females were examined for the presence of sperm in the vaginal tract. If sperm were present, the females were returned to individual housing; when sperm were not present, they were returned to cohabitation with their original or a new partner. The day vaginal sperm were confirmed was designated gestation day 0. Environmental conditions included: temperature, 22 • C ± 3 • C, humidity: 50% ± 20%, a 12-h on/12-h off lighting cycle, and approximately 10 room air changes per hour. Animals were given solid diet for experimental animals (CE-2; CLEA Japan Inc.) in food hoppers and tap water in polycarbonate water bottles. Food and water were available ad libitum.
Evaluative Parameters Used in all Experiments
Dosed females were examined twice daily for the presence of clinical signs suggestive of toxicological responses to administration of powdered FM. When dosing was terminated, animals were observed once a day. Food consumption was measured daily. Postmortem parameters such as necropsy, examination of uterine contents, and examination of the products of conception varied among the experiments and are described in detail below.
Statistical Analyses
Computed statistics, such as copulation, implantation, and fertility indices, were analyzed with Fisher's one-sided exact test.
The percentage data for litters in the second generation of the pre-and postnatal development study (live birth index; incidence of external abnormality; sex ratio; achievement of landmarks of physical development during the lactation period; viability index on day 4; lactation index; implantation index; and post implantation loss) were compared by Steel's method (1959) and, if significant differences resulted, the Jonckeere-Terpstra test (Jonckheere 1954) was performed for trends in dose-response relationship.
TABLE 3
Mean daily food consumption by presumed pregnant female rats dosed with powdered L. helveticus-fermented milk during mating and gestation a daily oral doses of powdered FM to females began 14 days before the mating trials. Dosing of males continued until the day of necropsy (conclusion of the mating period). Administration of powdered FM to females continued until gestation day 7. The first day of dosing was considered to be treatment day 1.
Animals were observed daily for mortality, morbidity and clinical signs (before and after powdered FM administration). Males were weighed on treatment days 1, 5, 9, 12, 16, 19, 23, and 26 , then weekly until sacrificed. Females were weighed on treatment days 1, 5, 9, and 12, then on gestation days 0, 4, 8, and 13. Food consumption by males was determined on treatment days 4, 8, 11, 15, 18, 22, and 25 , and that of females on treatment days 4, 8, and 11 and gestation days 0, 3, 7, and 12.
Mating and Analysis of Mating Behavior
One male and one female from the same dose group were housed together after powdered FM administration (treatment day 29 for the male and treatment day 15 for the female). They cohabited for a maximum of 2 weeks, during which time daily vaginal smears were executed to determine the presence of sperm.
Sperm-positive females were considered to have had successful copulation and that day was defined as gestation day 0. After successful copulation, females were separated from males. In the case of unsuccessful copulation (after 2 weeks of cohabitation), the male was remated with an untreated female, and the female was remated with a dosed male that had previously succeeded in copulating. If untreated females succeeded in copulating with a previously unsuccessful male, they were observed daily then sacrificed on gestation day 13. The females were then examined for the presence or absence of implantations in order to verify male fertility. Copulation and fertility indices were computed as the percent of males successfully copulating and the percent of copulated females impregnated.
Necropsy
After successful mating, males were euthanized by carbon dioxide inhalation and necropsied. On gestation day 13, females were similarly euthanized and subjected to complete necropsy and examination of ovarian and uterine contents. Major organs (brain; pituitary gland; liver; kidneys; spleen; and adrenal glands of male and female rats; ovaries and uterus with neck and oviduct for females; and testes, epididymes, seminal vesicles, and prostate for males) were dissected and weighed. Bilateral organs were weighed together. The organ weight data were expressed as absolute and relative (to body weight) weights. Animals proven to be infertile were excluded from statistical analysis. 
Examination of Reproductive Organs
Uteri were removed and examined to determine the numbers of implantation sites and living and dead embryos. Ovaries from all gravid females were examined to determine the number of corpora lutea. The implantation index and percent postimplantation loss were computed as the percent of corpora lutea resulting in implantation sites and the percent of implantation sites yielding living embryos, respectively. In addition to the organs listed for organ weight measurement, vagina and mammary glands of females, and all macroscopically abnormal organs were removed and preserved in 10% neutral-buffered formalin solution.
The testes were immersed in Bouin's solution and then washed in a solution of 70% ethanol saturated with lithium carbonate, and similarly preserved (Linder et al. 1992) .
The testes and epididymes from the first ten males in each group were embedded in paraffin, sectioned and stained for histopathological examination. Similarly, the ovaries of infertile females were preserved, sectioned, and stained for examination. For the testes, two transverse sections were made in two sites; one was stained with periodic acid Schiff's reagent (PAS) and the other with hematoxylin and eosin (H&E). The head, body, and tail of the epididymes were divided longitudinally, sectioned, and stained with H&E. Ovaries were divided longitudinally into four sections, and stained with H&E. All macroscopically abnormal organs and the corresponding organs from vehicle-control animals of the same sex were embedded in paraffin, sectioned, and stained with H&E. All the preparations were examined microscopically (Manson and Kang 1989; Russell et al. 1990; Bucci et al. 1997; Bolon et al. 1997) .
Assessment of Effects of Powdered FM on Embryo and Fetal Development Animal Mating
After acclimation to laboratory conditions, male and female rats were cohabited for 17 h; females were examined for the presence of vaginal sperm. The presence of sperm was taken as an indication of successful copulating and that day was referred to as gestation day 0. Mating and sperm checks were repeated until 84 mated females were accumulated. After being proven, sperm positive females were individually housed in stainless steel cages.
Experimental Groups and Powdered FM Dosage Regimen
Mated females were weighed on gestation day 0 and randomly assigned to one of four experimental groups. Each group consisted of 21 sperm-positive females designated to receive daily oral doses of powdered FM (0, 500, 1000, or 2000 mg/kg BW/day-equivalent to 0, 0.8, 1.6, or 3.3 mg of VPP plus IPP/kg BW/day-in groups G1, G2, G3, and G4, respectively). Although each group was initially comprised of 21 sperm-positive females, the actual numbers of pregnant animals were 20, 19, 20, and 20 in groups G1, G2, G3, and G4, respectively. Administration of powdered FM to pregnant females began on gestation day 7 and continued through gestation day 17 (11 consecutive days). Pregnancies were terminated on gestation day 20 by cesarean section.
Antemortem Evaluative Parameters
The following observations, measurements, and examinations were performed on all sperm-positive females, but records from animals later proven to be infertile were purged from the database. Animals were observed for mortality, morbidity, abortion, premature delivery of pups, and general clinical signs twice daily during the dosing period and once daily after dosing was terminated.
Animals were weighed on gestation days 0, 7, 10, 14, 17, and 20. Food consumption was estimated by the weight difference between food offered on the mornings of gestation days 9, 13, and 16 and the residue on the mornings of gestation days 10, 14, and 17, respectively.
Macroscopic Evaluative Parameters
On gestation day 20, animals were sacrificed with carbon dioxide and examined macroscopically. Abnormal or altered organs and the corresponding organs of vehicle control animals were removed and stored in 10% neutral-buffered formalin solution.
Each uterus was removed and examined for evidence of embryonic or fetal death and the number of live fetuses was determined. Dead embryos or fetuses were classified as having been an implantation site, placental remnant, resorption (early or late), macerated fetus, or dead fetus. For the dams with no implantations, the uterus was incised and examined with ammonium sulfide staining (Salewski 1964) . If this technique confirmed the absence of implantation sites, the animal was judged to have been infertile. Ovaries of all pregnant rats were examined and the number of corpora lutea counted. Implantation and postimplantation loss indices were computed.
Examination of Live Fetuses
Live fetuses were separated according to sex, individually weighed, and examined for external anomalies. Fetuses with grossly observable external malformations were fixed in 10% neutral-buffered formalin solution without being subjected to either skeletal or visceral examination. With the exception of any externally malformed fetuses, about half of each litter was allocated to skeletal examination and the remaining animals to visceral examination.
Visceral and skeletal observations were performed on the fetuses of all groups: G1, G2, G3, and G4. Visceral examinations were conducted by microdissection techniques (Nishimura 1974 ) after fixation of fetuses in Bouin's solution. Stereomicroscopic examinations of skeletons were conducted on alizarin red S-stained specimens (Dawson 1926) . Examinations were performed on all skeletons, but only data from bones with abnormalities or variation, and indicator bones for ossification are presented in summary tables.
Assessment of Effects of Powdered FM on Maternal Function and Pre-and Postnatal Development Animals, Mating, and Powdered FM Administration
After acclimation to laboratory conditions, nulliparous female rats were individually cohabited with males. After 17 h, the animals were separated for preparation of vaginal smears to verify the presence of sperm. The presence of sperm was considered to be indicative that copulation had occurred and that day was designated as gestation day 0. Cohabitation was repeated until 88 copulated females were accumulated. Copulated females were weighed on gestation day 0 and randomized into four groups, each consisting of 22 copulated females. Copulated females were housed individually (with their litters after birth) in plastic cages with wood chip bedding (Clean chip; Clea Japan, Inc.). The day that parturition was completed was referred to as lactation or postnatal day 0. Five additional pregnant females were reserved, untreated, to provide female offspring for possible use during the assessment of reproductive performance of the F 1 generation.
The five untreated, copulated females were allowed to deliver their offspring (F 1 animals), which were then culled into five pups per litter on postnatal day 4. At weaning, the maternal and unneeded F 1 animals were sacrificed without necropsy. Seven of the untreated F 1 animals were used for remating purposes to test mating behavior and fertility of treated F 1 males that were unsuccessful in their initial cohabitation trials.
The powdered FM was administered by oral gavage from gestation day 7 through lactation day 20. Doses were 0, 500, 1000, or 2000 mg of powdered FM/kg BW/day (equivalent to 0, 0.8, 1.6, or 3.3 mg of VPP plus IPP/kg BW/day) for groups G1, G2, G3, or G4, respectively. Pregnant females delivered offspring spontaneously. 
Disposition of F 1 Animals
On postnatal day 4, each litter was randomly culled to eight pups, four of each sex. Retained offspring were weaned on postnatal day 21, and one animal per sex from each litter was randomly selected for observations of behavior (emotionality and learning tests), organ weights, and macropathological examination on postnatal day 48. An additional 1 animal of each sex from each litter was selected for assessing body weights (after weaning), sexual maturity, reproductive capability, and macropathological examination after mating. The remaining animals were sacrificed and subjected to macropathological examination at weaning.
Observation and Disposition of F 0 Animals
Maternal animals were observed for clinical signs before and after powdered FM administration twice daily during the treatment period and once daily thereafter. Body weights were determined on gestation days 0, 4, 7, 10, and 14 to 21, and on lactation days 0, 4, 7, and 21. Food consumption was determined on gestation days 3, 9, 13, 16, and 20 and on lactation days 3, 6, 13 and 20.
Maternal animals were monitored for parturition on and after gestation day 20, and the gestation period (number of days from gestation day 0 to lactation day 0) was recorded and delivery index computed as the percent of pregnant animals that delivered living pups.
After weaning F 1 animals (lactation day 21), the dams were killed by carbon dioxide inhalation and examined macroscopically. Uteri were removed and the number of implantations was determined.
Observations of F 1 Animals
At parturition, offspring were sexed, examined for mortality and external abnormalities, and individually weighed. During the lactation period, the offspring were observed daily and weighed on postnatal days 0, 4, 7, 14 and 21. Stillbirths and pups that died during the lactation period were subjected to necropsy, including renal cross-sections. Pups culled on postnatal day 4 were sacrificed by carbon dioxide inhalation and macroscopically examined for vertical cross-section images of the kidney. The live birth index (percent of implant sites resulting in live births), viability index on day 4 (percent of live births that survived until day 4), and the lactation index (percent of pups at day 4 surviving until weaning) were computed. 
Assessment of Physical Development
Offspring were observed for achievement of the following landmarks of physical development (Fukunishi et al. 1998 ): (a) pinna detachment (both pinna) as determined on postnatal days 2 to 4; (b) incisor eruption (upper incisor) as determined on postnatal days 9 to 12; and (c) eye opening (both eyelids) as determined on postnatal days 12 to 16. The numbers of animals that achieved these landmarks were recorded per litter and per sex, and percentage achievements were calculated by the day of observation.
Development of Sensory Functions
Males and females (one of each per litter) designated for assessment of behavioral and sensory development (Adams et al. 1985) were tested for achievement of the following landmarks of sensory functional development and cumulative percentage achievements were calculated for each day of observation: (a) righting reflex as determined on postnatal days 6 to 10; (b) negative geotaxis as determined on postnatal days 7 to 12; (c) air righting reflex as determined on postnatal days 13 to 19; and (d) auditory startle reflex (scales 0 and 15 of Galton's whistle corresponding to about 4 and 16 kHz, respectively) as determined on postnatal days 18 to 19.
Macropathological Examination at Weaning
Two animals of each sex were selected for subsequent testing, and the remaining pups (two of each sex per litter) were killed by carbon dioxide inhalation and subjected to macropathological examination. Any kidneys that presented with macroscopic abnormalities were removed and fixed/stored in 10% neutralbuffered formalin solution.
Observation of F 1 Animals after Weaning
One male and one female pup per litter were used in an openfield test for assessment of emotional reactivity on postnatal days 26 to 29. Each animal was tested for 3 min on 2 consecutive days. Evaluative parameters included frequency of defecation and degree of ambulation. Ambulation was documented as a video image recorded during the experiment.
FIGURE 1
Macropathological observation on kidney from a group G3 female rat (1000 mg/kg/day of powdered L. helveticus-fermented milk). Kidney on left shows the recessed ridge, kidney on the right is normal. The powdered L. helveticus-fermented milk had been administered by oral gavage between gestation days 7 and 17.
One male and one female from each litter were tested in a water T-maze test for assessment of learning. Water maze testing was conducted on postnatal days 39 to 43. On the 1st day of exposure to the water maze, animals underwent three training trials in a straight course. On the 2nd and 3rd days, each animal had four trials in the T-maze course. Evaluative criteria included
FIGURE 2
Macropathological observation of splenic enlargement in a group G4 female rat (2000 mg/kg/day of powdered L. helveticus-fermented milk). Upper spleen is normal size. The powdered L. helveticus-fermented milk had been administered by daily oral gavage between gestation days 7 and 17. the number of errors and the time to reach the goal. Trials were limited to 3 min and any animals unable to reach the goal were removed from the course and given a time score of ≥3 min for the trial. Times for the animals unable to reach the goal were excluded from the calculation of group means and from statistical analysis of ranked data. 
Organ and Body Weights
F 1 animals used for behavioral observations were sacrificed by carbon dioxide inhalation and examined macroscopically on postnatal day 48. Organs dissected and weighed included brain; pituitary gland; liver; kidneys; spleen; and adrenal glands (both sexes); ovaries and uterus; and testes, epididymes, seminal vesicles, and prostate. Kidneys, lungs, and seminal vesicles with macroscopic abnormalities were fixed and stored in 10% neutral-buffered formalin solution, and the other organs and carcasses were discarded.
Physical Development Relative to Sexual Maturity
One male and one female per litter maintained for use in mating trials were observed for achievement of the following landmarks of physical development and recorded on the specified days until these differentiations were completed: (a) vaginal opening as observed on postnatal days 27, 34, and 41; and (b) cleavage of the balanopreputial gland (Korenbrot, Huhtaniemi, and Weiner 1977) as observed on postnatal days 34 and 41.
Assessment of Reproductive Ability of F 1 Animals
At the age of 10 weeks (postnatal day 70), male and female offspring in the same experimental groups were individually cohabited (avoiding sibling mating) for up to 2 weeks. The females were examined daily for sperm in the vagina and copulated females were separated from males. Males and females unsuccessful in copulating were cohabited with new partners. Females unsuccessful in copulating were housed with successful males, and unsuccessful males were housed with untreated females. Mating trials were terminated if animals were unsuccessful after four trials.
Body Weights of Pregnant Females
Copulated females were weighed on gestation days 0, 7 and 13. Females unsuccessful in copulating were excluded from statistical analysis. Untreated females that copulated were not weighed, but were observed daily and then sacrificed and examined for pregnancy on gestation day 13.
Macropathological Examinations of Pregnant F 1 Females
At the end of the mating period, all males and unsuccessful females were sacrificed by carbon oxide inhalation. Successfully copulated females were sacrificed on gestation day 13 and examined.
Uteri from the copulated females were removed to examine the pregnancy status (number of implantations and live fetuses). If no implantation sites were observed, the uterine horn was incised and tested with 10% ammonium sulfate stain (Salewski 1964) . The presence of implantation was regarded as a sign of pregnancy. Corpora lutea were counted; copulation, fertility and implantation indices, and percent of postimplantation loss were computed. Organs removed and preserved after macropathological examination included macroscopically abnormal tissues; ovaries; uterus including neck and horns; vagina; and mammary glands; testes; epididymes; seminal vesicles; and prostate. Testes were immersed in Bouin's fixative, washed with lithium carbonate saturated 70% ethanol, and refixed and stored in 10% neutral-buffered formalin solution. The other organs were fixed and stored in 10% neutral-buffered formalin solution.
RESULTS
Assessment of Effects of Powdered FM on Fertility and Embryogenesis Clinical Signs and Growth
Administration of powdered FM to male and female rats prior to mating or to pregnant females produced no clinical signs indicative of systemic toxicity. A single group G1 male had loose stool on dosing day 2, but at no other time. All animals survived until the scheduled termination of the study.
All rats of both sexes increased their individual body weights during the study and powdered FM was without effect on body weight gains. Mean body weights of male and female rats during the premating treatment administration phase and of females during the gestation period are summarized in Table 2 . Consistent with identical weight gains in all experimental groups, food consumption by copulated females was unaffected by the administration of powdered FM (Table 3) .
Absolute and relative (to body weight) organ weights of parental animals are summarized in Tables 4 and 5 . Variations in absolute organ weights were small, without statistical significance, and afforded no evidence of dose dependency. Because terminal body weights were unaffected by administration of powdered FM, it is not surprising that relative organ weights were unaffected by the dosage regimen.
Macro-and Microscopic Examinations
Necropsy of males (after successful mating) and females (after sacrifice on gestation day 13) revealed no grossly observable signs suggestive of powdered FM-associated toxicity (Table 6) . Findings in males included dilated renal pelvis in a vehicle- control group animal, white spots in the epididymis of a single group G2 animal, and a thyroid gland nodule in a group G3 animal. The only observed abnormality in females was a rudimental uterine horn in a group G1 animal. Macroscopic findings in bilateral organs were consistently unilateral. Microscopic examination of all abnormal organs revealed increased fibrous tissue in the thyroid gland of the G3 male, spermatic granuloma in the epididymal tails of both the G2 and 28.0 ± 2.3 26.0 ± 3.5 25.4 ± 2.9 25.9 ± 2.9 23.0 ± 5.5 47.5 ± 5.7 48.7 ± 3.9 65.7 ± 6.7 82.2 ± 7.0 G4 2000 26.1 ± 3.3 24.8 ± 4.5 25.2 ± 3.2 25.8 ± 3.4 24.0 ± 4.9 46.3 ± 5.5 50.5 ± 5.5 67.0 ± 5.6 84.1 ± 9.5 a Data expressed as mean ± SD (n = 22).
G4 males, and dilated renal pelvis in a G1 male. No microscopic changes were observed in the uterus of the G1 female with the rudimental uterine horn.
Mating Performance and Fertility
Mating performance is summarized in Table 7 . With the exception of a single group G2 couple, all pairs successfully copulated during the initial mating trial. Both of the unsuccessful partners successfully mated with new partners during a second mating trial.
Infertility was observed in one female in each of the G1, G2, and G4 groups. Macro-and microscopic examination of the reproductive tracts of the infertile females revealed no evidence of reproductive abnormalities such as alterations of numbers of differential follicular cells or depletion of primordial follicle. The mean numbers of estrous cycles required for pregnancy and the copulation and fertility indices were comparable between the vehicle-control and powdered FM-dosed groups.
FIGURE 5
Macropathological observation of a fetus with a 14th rib. Fetus was carried by a female rat that had been dosed orally with powdered L. helveticus-fermented milk (2000 mg/kg/day) between gestation days 7 and 17.
Assessment of Ovarian and Uterine Contents
Ovarian and uterine data for copulated females sacrificed on gestation day 13 are summarized in Table 8 . Twenty-one females in each group had successfully copulated (Table 7) , 20/21 (95.2%) of the females in groups G1, G2 and G4 were pregnant, and all group G3 females were pregnant. All pregnant females carried live fetuses and the mean numbers of corpora lutea were similar in all groups, ranging from 14.5 to 15.7 in groups G4 and G2, respectively. The small difference in mean numbers of corpora lutea was not statistically significant.
The implantation index was similar in all groups, ranging from 94% to 97.4% in the G2 and G4 groups, respectively. The percent of fetuses alive on gestation day 13 was greater than 90% in all groups and the mean incidence of dead fetuses per dam ranged from 0.6 in group G4 to 1.2 in group G2.
FIGURE 6
Macropathological observation of a fetus with a shortened 13th rib. The fetus was carried by a female rat that had been dosed orally with powdered L. helveticus-fermented milk (2000 mg/kg/day) between gestation days 7 and 17. 
Male (mean ± SD) 6.9 ± 0.5 7.0 ± 0.5 6.8 ± 0.6 6.8 ± 0.5 Female (mean ± SD)
6.4 ± 0.5 6.5 ± 0.5 6.5 ± 0.6 6.4 ± 0.6 a Data expressed as mean ± SD (percentage).
Assessment of Effects of Powdered FM on Embryo and Fetal Development Clinical Signs and Growth
Administration of powdered FM to pregnant rats produced no clinical signs suggestive of either systemic or local toxicity. All pregnant animals survived until their scheduled day of cesarean section (gestation day 20) and there were neither spontaneous abortions nor premature births. All animals gained weight during the study and mean body weights of the treatment groups were comparable to those of vehicle controls throughout the pregnancy period (Table 9) . Similarly, food consumption by rats in the treatment groups was comparable to those of vehicle-control animals throughout the pregnancy period (Table 10) . 
Macropathological Observations
Necropsy examination of dams after cesarean delivery of litters revealed few grossly observable changes. The observations are listed in Table 11 and shown photographically in Figures 1 through 3.
One group G3 dam exhibited a recessed area in her right kidney (Figure 1) . A group G4 animal had an enlarged spleen (Figure 2) while another high-dose group animal exhibited an inguinal, subcutaneous mass (Figure 3) . Additional gross lesions were not observed. Because each of the changes occurred in single animals of diverse groups none were considered to be attributable to administration of powdered FM.
Maternal and Fetal Findings at Caesarean Section
Intrauterine maternal and fetal parameters assessed at the time of cesarean section are summarized in Table 12 . All dams carried live fetuses and the mean number (12.4 to 14.8) and percent live fetuses (89.1 to 96.3) were similar in all groups. The numbers of corpora lutea were also similar in all animals.
The implantation indices for groups G3 and G4 were significantly reduced (12% and 6%, p < .01 and .05, respectively), although there was no evidence of dose dependency in the magnitude of the difference. The powdered FM was without effect on the sex ratio of pups and mean fetal body weights were similar in all groups. A single fetus from a group G3 female was observed to have been edematous (Figure 4) .
Observations Made during Visceral Examinations of Fetuses from Control and High-Dose Dams
Visceral anomalies observed in fetuses delivered from groups G1 and G4 rats administered powdered FM are summarized in Table 13 . The most frequently encountered change was the presence of thymic remnants in the necks of 10 fetuses from vehiclecontrol dams and 9 fetuses from high-dose dams. One fetus from a control dam exhibited dilation of the cerebral ventricles, but this change was not observed in dosed animals. Persistent left umbilical arteries were observed in one vehicle-control fetus and two fetuses from group G4 dams. None of these changes are considered attributable to administration of powdered FM.
Observations Made during Skeletal Examinations of Fetuses from Control and High-Dose Dams
No skeletal abnormalities were observed in fetuses from either vehicle-control or high-dose powdered FM dams. The incidences of skeletal variations in fetuses delivered from control and powdered FM-dosed rats are summarized in Table 14 . The most frequently encountered variation, the presence of a 14th rib, was observed in 12 fetuses from 8 different vehicle control dams, and in 13 fetuses from 9 different dams dosed with 2000 mg of FM/kg BW/day (equivalent to 3.3 mg VPP plus IPP/kg BW/day). The 14th rib in a fetus from a powdered FM-dosed female is shown in Figure 5 . A shortened 13th rib was observed in four fetuses from three different dams dosed with 2000 mg FM/kg BW/day (3.3 mg VPP plus IPP/kg BW/day). This variation was not observed in fetuses from vehicle-control dams. A shortened 13th rib is shown in Figure 6 . The small differences in incidences between vehicle-control and the highdose group did not achieve statistical significance.
During assessment of ossification of fore-and hind limb phalanges, small (5% to 12%), but statistically significant (Student's t test, p < .05), increases in the numbers of ossification sites were observed in fetuses from dosed females relative to vehicle controls. Thus, the same skeletal observations were conducted on the fetuses from groups G2 and G3. The complete data set was reanalyzed by analysis of variance and no statistically significant differences were observed among experimental groups, including the 2000 mg of powdered FM/kg BW/day (3.3 mg of VPP plus IPP/kg BW/day) group.
Assessment of Effects of Powdered FM on Maternal Function and Pre-and Postnatal Development
Observations of F 0 and F 1 Animals during Gestation and Rearing
All maternal animals survived for the duration of the experiment (through lactation day 20), and there were neither abortions nor premature deliveries. Clinical signs exhibited by pregnant females were nonspecific, generally occurred in only one animal, and there was no evidence of dose dependency. One group G4 animal had an upper jaw injury on gestation day 6. This had a transient effect on food consumption and body weight gain, but that animal delivered and reared her pups normally. A group G3 animal exhibited fur loss on her chest between gestation day 14 and lactation day 19. Mean body weights of F 0 rats were unaffected by administration of powdered FM either during pregnancy or during the period of lactation (Table 15) . Similarly, food consumption was unaffected by powdered FM administration. Although the gestation days 9 to 10 mean food consumption by group G4 was numerically reduced (approximately 6%), this small change, attributed to the injured animal described above, was not statistically significant (Table 16 ). The reduction in food consumption during the injury appeared to also be reflected by a transient but insignificant numerical reduction in group G4's mean body weight on gestation day 7.
Parameters recorded at the parturition of F 0 females are summarized in Table 17 . All 22 animals in each experimental group delivered live offspring with the mean gestation periods ranging from 22.1 to 22.5 days. The number of stillborn pups, 3, 3, 2, and 7 in groups G1, G2, G3, and G4 respectively, were not significantly different. Sex ratios were similar for each experimental group as were mean body weights of fetuses. No offspring were observed to have grossly observable abnormalities.
Viability of offspring is summarized in Table 18 . Percent of offspring surviving between postnatal days 1 and 4 were 97.9, 97.8, 98.6, and 97.6 in groups G1, G2, G3, and G4, respectively. After litter culling on postnatal day 4, each experimental group contained 176 offspring. All but a single vehicle-control pup survived until weaning on lactation day 21. F 0 animals were sacrificed at weaning of the F 1 generation and macroscopic examination revealed no treatmentassociated changes. Observations of weaned F 1 animals revealed no differences between groups with respect to spontaneous behavior.
Observations of F 1 Animals after Weaning
Mean body weights of male and female members of the F 1 generation between weaning and postnatal day 69 are summarized in Table 19 . Exposure of the F 1 animals to powdered FM was without effect on either rate or magnitude of body weight gain.
Times to achievement of landmarks of physical development (pinna detachment, eye opening and incisor eruption) are summarized in Table 20 . These data are presented as cumulative percentages of animals achieving the landmark on the indicated day. There were no significant differences in the rates or the incidences of achievement of the indicators of physical development. Similarly, physical development relating to sexual maturity was unaffected by administration of powdered FM (Table 21) . Achievement of cleavage of the balanopreputial gland of males and vaginal opening of females did not differ between the vehicle control and treatment groups.
Mean times to achievement of sensory functions are shown in Table 22 . A significant decrease in percent of animals achieving the mid air righting reflex was observed in both sexes of offspring of the G4 group on day 13 after birth. Males from group G3 exhibited a decrement in achievement of the mid-air righting reflex on day 14. The surface righting reflex was conducted on the day (postnatal days 6 to 10), the period during which this function is normally achieved. Times to achievement of the righting reflex, negative geotaxis, and auditory startle reflex did not differ between the vehicle control and treatment groups.
The results of the open-field emotionality test are summarized in Table 23 . Ambulation and the incidence of defecation were unaffected by animals' earlier exposures to powdered FM.
The results of assessments of learning ability in the water maze are summarized in Table 24 . Failure of rats to reach the goal within the arbitrary 3-min limit was rare and in only three trials did as many as two rats fail (group G3 males, third trial, day 2; group G2 females, fourth trial, day 2; and group G4 females, first trial, day 2.). The number of errors was increased in the group G2 males during the fourth trial of the 3rd day of exposure to the maze, but there was no evidence of a dose-response relationship on that day and error rates were similar for control and exposed animals of either sex for the rest of the experiment. The mean time to reach the goal was prolonged in the group G4 males during the fourth trial of the 3rd day of exposure to the maze, but there was no trend toward prolongation in the other treatment groups and there was no evidence of a decrement during trials on day 3.
Reproductive Performance of F 1 Generation Animals
Mating behavior of F 1 rats is summarized in Table 25 . Copulation and fertility indices did not differ significantly between the vehicle control and treatment groups. Although copulating was not initially successful in one, one, one, and four pairs, respectively, in groups G1, G2, G3, and G4 during the initial cohabitation, all animals were successful after re-mating with a different partner. Infertility occurred in one, one, and two females, respectively, in groups G2, G3, and G4 that had copulated during the initial mating and in the replaced, untreated female partner of one of the group G4 males during the remating trial.
No abnormal clinical signs were observed in the vehiclecontrol and treatment groups including infertile females. Body weights during pregnancy did not differ between the vehiclecontrol and treatment groups.
Gestation day 13 ovarian and intrauterine data from F 1 females are summarized in Table 26 . The numbers of corpora lutea and implantations were similar in all groups and the mean implantation index ranged from 14.9 in group G2 to 15.5 in group G3. All pregnant rats carried live fetuses and the mean number of dead fetuses was less than 1 per litter, ranging from 0.5 in group G2 to 0.9 in group G1. 
Macroscopic Examinations
The macroscopic observations during the necropsy of animals from the F 1 generation are summarized in Table 27 . The data are stratified according to disposition of animals during the experiment.
No macroscopic changes were observed in the offspring that died at delivery, during lactation, or those culled on postnatal day 4. The negative data for these animals are not included in Table 27 .
Among rats sacrificed at weaning, dilation of the renal pelvis was observed in two male and one female group G1 offspring, and in one G2 and two G4 males. Changes were unilateral in most animals, but the single affected G4 female exhibited a bilateral change.
In the offspring necropsied on postnatal day 48 (used for behavioral observations), unilateral dilated renal pelvis was observed in four, four, three, and two male offspring in groups G1, G2, G3, and G4, respectively; unilateral discolored renal plaques in one male in each of the treatment groups; unilateral cystic renal cortex in one male each in the G2 and G3 groups; and small seminal vesicles (bilateral) in one group G4 male. Female offspring exhibited unilateral dilated renal pelvis (one animal from group G2) and bilateral dilated renal pelvis in one animal from group G3.
A group G4 male offspring that swam in the test maze on the "training" day was found dead in the next morning. Necropsy revealed dark red lungs and the death of this animal was attributed to inhalation of water during swimming. For the offspring tested for reproductive capabilities, necropsy revealed dilated renal pelvis (unilateral) in four, five, one, and three males from groups G1, G2, G3, and G4, respectively; unilateral discolored renal plaques in one, two, and one males from groups G1, G2, and G4; unilateral small seminal vesicle in one male each in groups G1 and G2; and bilateral small seminal vesicles in one G4 male. In females, unilateral dilated renal pelvis was observed in two G2 and one G3 animals; unilateral discolored plaques in one G1 animal; bilateral dilated renal pelvis in one female in groups G1 and G4, respectively; and bilateral cystic renal cortex in one group G1 animal. These findings were all identified in animals that had been pregnant.
Organ weights from F 1 animals are summarized in Tables 28  and 29 . Significantly decreased absolute weights of male and female brains, male prostate, and female uterus were observed in group G4 animals. The decrease in absolute brain weight appeared dose-related down to 1000 mg FM/kg BW/day (1.6 mg VPP plus IPP/kg BW/day) for males, and 500 mg FM/kg BW/day (0.8 mg of VPP plus IPP/kg BW/day) for females. The decrease in absolute prostate weight down to 1000 mg FM/kg BW/day (1.6 mg of VPP plus IPP/kg BW/day) for males also appeared dose-related. A significantly decreased relative adrenal weight was observed for males in group G4, but there was no trend toward reduction in the other treatment groups.
DISCUSSION
The studies described in this paper sought to evaluate the potential reproductive effect (e.g., mating behavior, fertility) of powdered FM administered orally to rats in doses of 500, 1000, or 2000 mg/kg BW/day (equivalent to 0.8, 1.6, or 3.3 mg VPP plus IPP/kg BW/day), respectively. No signs of systemic toxicity were observed; body weights, food consumption, and absolute and relative organ weights were similar across groups of control and treated rats. Similarly, powdered FM was without effect on either mating behavior or fertility. Although a single pair of rats failed to copulate during the 2-week cohabitation period, both of the animals were successful when paired with new partners.
Examination of ovarian and uterine contents of female rats sacrificed on gestation day 13 yielded no evidence of embryotoxicity. The mean numbers of implant sites per impregnated female were similar in all experimental groups, as were the mean numbers of living and dead fetuses in each group. Macroscopic examination at necropsy of all experimental animals revealed few changes, none of which were considered attributable to administration of powdered FM. The fertility of a single male dosed with the 500 mg/kg BW/day dose of powdered FM (0.8 mg VPP plus IPP/kg BW/day) was not proven during the mating phase of the experiment. At necropsy, this animal exhibited atrophied seminiferous tubules and his epididymal ducts contained degenerated spermatozoa. These microscopic findings explain the animal's infertility, but cannot be considered secondary to administration of powdered FM.
During the evaluation of fetal development, the administration of 1000 and 2000 mg/kg BW/day of powdered FM (1.6 and 3.3 mg VPP plus IPP/kg BW/day) was associated with a significantly decreased implantation index. Comparison of the data to historical control data from contemporary experiments conducted in this strain of rats revealed that the mean implantation indices in the powdered FM-dosed animals (86.9% and 92.1%, respectively), although significantly lower than that of the concurrent vehicle-control value, were actually comparable to the historical control data from six studies performed during the previous 4 years (90.9% ± 5.7%) involving 80 vehicle-control dams. In light of the historical control implantation indices, the small differences observed in this study were most likely attributable to an abnormally high index in concurrent control animals (98.4%) rather than to administration of the test substance.
A skeletal variation, shortened 13th rib, not observed in the vehicle-control group, was present in four fetuses from three dams (mean incidence 2.4% per affected dam) in the 2000 mg powdered FM group (equivalent to 3.3 mg VPP plus IPP/kg BW/day). Although somewhat elevated relative to our historical control background data of 1.4% in five studies in this strain of rats, the difference is not considered to be treatment-related; it was not significantly statistically different from controls.
In the case of ossification, a significant increase in mean foreand hind limb phalange ossification numbers was observed in the offspring of dams dosed with 2000 mg of powdered FM/kg BW/day (3.3 mg VPP plus IPP/kg BW/day). However, no significant difference was observed when the data were compared by a multiple-sample comparison method that incorporated ossification numbers of fetuses from the low-and mid-dose groups. Consequently, this small change is not considered to be treatmentrelated.
Administration of powdered FM to pregnant and lactating dams produced no evidence of toxicity in either the F 0 or F 1 generation. The F 1 animals exhibited no external abnormality, and there were no dosing attributable effects on F 1 generation live births sex ratio, body weights at birth, pup viability, or clinical signs during lactation and after weaning. Physical and behavioral development, as evidenced by assessment of attainment of landmarks of physical, sexual, and sensory maturity, were unaffected by administration of powdered FM to the dams.
In the sensory function test, percent achievement of air righting was decreased in male and female F 1 animals in the 2000 mg FM/kg BW/day group (equivalent to 3.3 mg VPP plus IPP/kg BW/day) on postnatal day 13 and in males from the 1000 mg of powdered FM/kg BW/day group (equivalent to 1.6 mg VPP plus IPP/kg BW/day) on postnatal day 14. These  TABLE 28 
